The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Isolagen Inc  (ILE) Trade Now »     Rate ILE  -  Discuss ILE  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
This is a micro-cap stock and may be a target of manipulation. Always do your research!

SocialPicks Sentiment:
N/A

** not enough data to be rated 		This Quarter's Sentiment:
All:
100.0%
Top:
100.0%
Rate ILE:


Home
Analysis & Videos
Quotes
Bull or Bear
Discuss
        

ILE: Bull or Bear? From:    SocialPicks  |  Blogsphere  |  All

From the Blogosphere

Updated Clinical Trial and FDA Calendars
Mikerun
73%
Below is a summary of updates to the www.BioMedReports.com database of 242 entries included in the FDA and Clinical Trial Calendars. The two web links below are for the FDA calendar home page and a recent article highlighting 14 extreme trades of companies with market caps below $200M with pending FDA decisions.

http://biomedreports.com/fda-calendar.html

http://biomedreports.com/articles/most-popular/627-trading-fda-decisions-14-extreme-trades.html

The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FDA sorted by their PDU...
By  Mike Havrilla   (+1.04%  risk: conservative)  03/15/09 Comment


Trading FDA Decisions: 14 Extreme Trades
Mikerun
73%
Below is a summary of companies from the BioMedReports.com FDA Decision Date Calendar which have market caps below $200M, making them ideal candidates for extreme stock price volatility trades as their decision dates become imminent.

Dyax Corp. (DYAX) secured a narrow approval from a FDA Advisory Panel in early February (with a 6-5-2 vote) for its Kalbitor (ecallantide or DX-88) BLA with a PDUFA date of 3/23/09, which is designated for priority review in the treatment of acute attacks of hereditary angioedema (HAE is a rare disorder marked by severe swelling which can be fatal if the throat ...
By  Mike Havrilla   (+1.04%  risk: conservative)  03/11/09 Comment


Stem Cell Index Soars on Lift of Funding Ban
Mikerun
73%

<>The accompanying table includes statistics for the 40 companies in the ETF Innovators Global Stem Cell and Regenerative Medicine Index, which is down 14.2% at a value of 3,387 from a 2/22/09 inception date value of 3,928. Most of the stocks got a major boost today from the widely anticipated executive order from President Obama to eliminate the restrictions on federal funding of stem cell research enacted in 2001 under President George W. Bush.

The move allows federally funded researchers to use hundreds of new embryonic stem cell lines for what remains long-term but very promising research ...
By  Mike Havrilla   (+1.04%  risk: conservative)  03/10/09 Comment


Analysis of Stem Cell Index YTD
Mikerun
73%
The accompanying table includes statistics for the 40 companies in the ETF Innovators Global Stem Cell and Regenerative Medicine Index, which is down 13.8% at a value of 3,387 from a 2/22/09 inception date value of 3,928.

The index is down 30.6% over the past year on an equal-weight basis, compared to losses of 31.2% for the Healthcare Sector SPDR (XLV), 19% for iShares Nasdaq Biotech (IBB), 14.7% for SPDR S&P Biotech (XBI), 29.7% for PowerShares Biotech & Genome (PBE), and 46.1% for the S&P 500 SPDR (SPY).

Below is a profile for each company, including a summary of their business and researc...
By  Mike Havrilla   (+1.04%  risk: conservative)  03/08/09 Comment


Global Stem Cell and Regenerative Medicine Index
Mikerun
73%


The accompanying table (click to enlarge) includes 40 companies in the ETF Innovators Global Stem Cell and Regenerative Medicine Index, which represents an expansion of the Emerging Stem Cell Index I have written about previously. The expanded global index includes companies with market caps less than $1B at the index inception with a total market value of $3,814 as of the close today. As previously, I will track the total market value for a more comprehensive gauge of investor sentiment toward the space.

The index is down 16.2% over the past year on an equal-weight basis, compared to losses...
By  Mike Havrilla   (+1.04%  risk: conservative)  02/18/09 Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.44% 381
2 Gerald Greene 18.14 +71.24% 211
3 stockmarketfunding.com 17.66 +25.60% 55
4 akiralegrand 13.47 +14.32% 62
5 anup2104 12.13 +74.22% 40


POPULAR STOCKS
Symbol Company Name Sentiment
WFC Wells Fargo & Company
YHOO Yahoo! Inc
INTC Intel Corp
EBAY eBay Inc
MSFT Microsoft Corp
GS Goldman Sachs Group Inc The

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on ILE

Visit streetinsider.com


Discussion Wall + Add  

Be the first to start a discussion and earn 2 points.



More Resources

Graphic_arrow1 About Isolagen Inc - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch